In vitro removal of anti-infective agents by a novel cytokine adsorbent system
暂无分享,去创建一个
J. Roberts | C. König | D. Wichmann | A. Nierhaus | S. Braune | S. Kluge | A. Brinkmann | O. Frey | Anka C. Röhr
[1] A. Brinkmann,et al. [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?] , 2016, Medizinische Klinik, Intensivmedizin und Notfallmedizin.
[2] M. Singer,et al. International registry on the use of the CytoSorb® adsorber in ICU patients , 2019, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[3] F. Siemers,et al. Continuous Hemoadsorption with a Cytokine Adsorber during Sepsis – a Review of the Literature , 2017, The International journal of artificial organs.
[4] U. Holzgrabe,et al. Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin , 2017, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[5] A. Röhr,et al. Therapeutisches Drug Monitoring und individualisierte Dosierung von Antibiotika bei der Sepsis , 2016, Medizinische Klinik - Intensivmedizin und Notfallmedizin.
[6] Kathleen Jodoin. The Renal Drug Handbook: The Ultimate Prescribing Guide for Renal Practitioners, 4th edition , 2016 .
[7] G. Fischer,et al. Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure , 2016, Case reports in critical care.
[8] A. Torres,et al. Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements , 2015, Antimicrobial Agents and Chemotherapy.
[9] J. Gummert,et al. First Successful Combination of ECMO with Cytokine Removal Therapy in Cardiogenic Septic Shock: A Case Report , 2015, The International journal of artificial organs.
[10] J. Roberts,et al. Anti-Infective Drugs during Continuous Hemodialysis –Using the Bench to Learn What to do at the Bedside , 2015, The International journal of artificial organs.
[11] Rajeev Chaudhry,et al. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study , 2014, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.
[12] P. Honore,et al. Newly Designed CRRT Membranes for Sepsis and SIRS—A Pragmatic Approach for Bedside Intensivists Summarizing the More Recent Advances: A Systematic Structured Review , 2013, ASAIO journal.
[13] J. Vincent,et al. Red blood cell transfusion in the critically ill patient , 2011, Annals of intensive care.
[14] John A Kellum,et al. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats , 2008, Critical care medicine.
[15] J. Kellum,et al. Feasibility study of cytokine removal by hemoadsorption in brain-dead humans* , 2008, Critical care medicine.
[16] D. Fliser,et al. Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis* , 2006, Critical care medicine.
[17] R. Bellomo,et al. In vitro Removal of Therapeutic Drugs with a Novel Adsorbent System , 2002, Blood Purification.
[18] G. Park,et al. The role of albumin in critical illness. , 2000, British journal of anaesthesia.
[19] N. Frimodt-Møller,et al. Dicloxacillin and flucloxacillin: Pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration , 1995, Infection.